Lever
Lifestyle
- Regular physical activity
- Weight management
- Stress reduction
Blutwerte · Marker
C-Peptid
C-Peptide · Connecting Peptide
Stoffwechsel & GlukoseNüchtern erforderlichZeitabhängig
- Einheit:
- nmol/L
- Abbreviation
- C-Peptide
C-Peptide quantifies the secretion of insulin by measuring the byproduct released during insulin production.
Reference Ranges
Reference
0.2–0.6nmol/L
0.2
0.6
LowNormalHigh
Reference
Unit · nmol/LFasting samples preferred; variability between labs due to assay differences.
Overview
Übersicht
C-Peptide, also known as Connecting Peptide, is a byproduct of insulin production, released in equimolar amounts with insulin from the pancreas. It serves as a marker for endogenous insulin secretion, reflecting beta-cell function. Clinically, C-Peptide is crucial in differentiating between type 1 and type 2 diabetes, assessing residual beta-cell function, and guiding treatment decisions. It is particularly valuable in distinguishing between insulin-dependent and non-insulin-dependent diabetes. In athletic performance and biohacking, C-Peptide levels may provide insights into metabolic health and insulin sensitivity, although its direct impact on performance or longevity is less clear. Researchers observed that C-Peptide measurement can be confounded by factors such as assay variability, fasting status, and time of day. Standardization of assays is needed to improve reliability. Fasting samples are often preferred, and levels may vary throughout the day, necessitating consistent timing for accurate monitoring.
Klinische Bedeutung
Elevated C-Peptide levels may indicate insulin resistance or type 2 diabetes, while low levels suggest reduced beta-cell function, often seen in type 1 diabetes or advanced type 2 diabetes.
Dynamics
Trend Interpretation
Rising Values
Progressively rising values suggest worsening insulin resistance or beta-cell hyperactivity. Retest in 3-6 months.
Falling Values
Progressively falling values may indicate declining beta-cell function or improved insulin sensitivity.
Re-test Interval
4 weeks if outside optimal range
Etiology
Causes — High & Low
Cause
Elevated Levels
- Insulin resistance
- Type 2 diabetes
- Obesity
- Insulinoma
- Renal failure
Cause
Low Levels
- Type 1 diabetes
- Advanced type 2 diabetes
- Pancreatic surgery
- Severe beta-cell dysfunction
Protocol
How to Optimize
Lever
Nutrition
- Low glycemic index diet
- High fiber intake
Note:
Consult a healthcare provider for personalized advice, especially if considering changes to diabetes management.
Testing Guidelines
🍽️Fasting Required
🕐Time-Sensitive
Levels may vary; consistent timing is recommended for repeat tests.
Testing Frequency
Annually for diabetes management, more frequently if adjusting treatment.
Interfering Factors
- Recent intense exercise
- Acute illness
Related Peptides & Hormones
Insulin
hormone or peptideDirectly measures
Open Research Questions
Current research suggests that the standardization of C-peptide measurements remains a significant challenge, leading to variability in results across different assays, which complicates the establishment of reliable reference ranges and optimal targets for diabetes classification. Researchers have not yet established the full clinical utility of C-peptide in type 2 diabetes due to confounding factors like insulin resistance. Additionally, unanswered clinical questions include the precise role of C-peptide in guiding treatment decisions and its implications for long-term diabetes management.
24 Research Publications
707
Total Citations
6
Human/RCT
6.7
Avg. Influence
2024
Latest
Sort
Filter
01Top
#01
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.
ReviewInfluence21.0
222
This study examined various laboratory tests used for diagnosing and managing diabetes mellitus, including C-peptide measurement. Researchers found that while C-peptide can provide insights into beta-cell function, its clinical utility is limited due to variability in assay standardization. The guidelines recommend specific tests based on evidence and expert consensus.
02Top
#02
Proinsulin and C-peptide: a review.
ReviewInfluence5.0
139
Researchers reviewed the role of proinsulin and C-peptide in insulin production and beta-cell function. They found that while proinsulin has some biological activity, C-peptide is biologically inert but crucial for assessing beta-cell function in diabetic patients. Recent advancements allow for more specific measurement of C-peptide.
03Top
#03
C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective.
ReviewInfluence5.0
110
Researchers found that C-peptide measurement is valuable for assessing beta-cell function and classifying diabetes types. The study highlighted that while C-peptide is useful in autoimmune diabetes, its role in type 2 diabetes is limited due to insulin resistance and assay standardization issues. The review calls for reliable markers to aid in diabetes management.
04
#04
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.
ReviewInfluence4.0
94
This study reiterated the importance of various laboratory tests for diabetes management, including C-peptide. Researchers observed that while C-peptide can indicate beta-cell function, its measurement is not universally recommended due to the lack of clinical value in some cases. The guidelines emphasize evidence-based recommendations for diabetes diagnostics.
05
#05
Implementing a Reference Measurement System for C-Peptide: Successes and Lessons Learned.
ReviewInfluence3.0
46
This study reviewed efforts to standardize C-peptide measurement across laboratories. Researchers found that harmonization of C-peptide results is crucial for accurate diabetes management and research. The review outlines challenges faced in implementing a reference measurement system for C-peptide and suggests collaborative efforts for improvement.
06
#06
Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes.
Unknown
26
This study provided evidence for using C-peptide as a biomarker in type 1 diabetes clinical trials. Researchers found that C-peptide levels correlate with β-cell function and clinical outcomes, suggesting its potential as a meaningful measure for evaluating new therapies.
07
#07
Evaluation of hemolysis, lipemia, and icterus interference with common clinical immunoassays.
In Vitro
24
Researchers evaluated how hemolysis, lipemia, and icterus affect clinical immunoassays, including C-peptide assays. They found that hemolysis can significantly impact C-peptide measurement, potentially leading to inaccurate results. The study provides important insights for laboratories to ensure accurate reporting of immunoassay results.
08
#08
C-peptide in diabetes: A player in a dual hormone disorder?
ReviewInfluence2.0
17
Researchers examined the multifaceted role of C-peptide in diabetes, noting its anti-inflammatory properties in type 1 diabetes and its potential contribution to complications in type 2 diabetes. The study suggests that C-peptide may serve as a biomarker for insulin resistance and cardiovascular risk in diabetes management.
09
#09
Insulin murder and the case of Colin Norris.
Human
9
This study examined the potential of C-peptide testing for early diagnosis of gestational diabetes. Researchers found that elevated C-peptide levels in early pregnancy could indicate a higher risk of developing gestational diabetes, suggesting a need for preventive strategies.
10
#10
Interlaboratory Comparison of Antibody-Free LC-MS/MS Measurements of C-peptide and Insulin.
In Vitro
8
This study assessed the interlaboratory comparability of C-peptide measurements using LC-MS/MS. Researchers found that the method demonstrated high precision and linearity, suggesting it could improve standardization in diabetes research and patient care.
Publication Trend
Research publications about C-Peptid over time
9totalTrack your bloodwork in PepStack
Log lab results, track trends and optimize your biomarkers over time.
Legal Disclaimer
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer